Amryt Pharma Holdings Ltd banner

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Market Cap: £457.1m

Wall Street
Price Targets

AMYT Price Targets Summary
Amryt Pharma Holdings Ltd

There are no price targets for AMYT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Amryt Pharma Holdings Ltd Competitors:
Price Targets
OFN
Orell Fuessli AG
6% Upside
SITOWS
Sitowise Group Oyj
3% Upside
IT
Gartner Inc
77% Upside

Revenue
Forecast

229% / Year
Past Growth
32% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
229% / Year
Past Growth
32% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 4 years the compound annual growth rate for Amryt Pharma Holdings Ltd's revenue is 229%. The projected CAGR for the next 5 years is 32%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMYT's stock price target?
Not Available

AMYT doesn't have any price targets made by Wall Street professionals.

What is Amryt Pharma Holdings Ltd's Revenue forecast?
Projected CAGR
32%

For the last 4 years the compound annual growth rate for Amryt Pharma Holdings Ltd's revenue is 229%. The projected CAGR for the next 5 years is 32%.

Back to Top